Regulatory authorities in Brazil have approved the oral therapy Tavalisse (fostamatinib disodium hexahydrate) for adults with chronic …
Immune thrombocytopenia
Spleen tyrosine kinase (SYK) inhibitors, including Tavalisse (fostamatinib disodium hexahydrate), may be effective treatments for adults with chronic primary ITP,…
Six people with treatment-resistant immune thrombocytopenia (ITP) and underlying systemic lupus erythematosus (SLE) all achieved clinical responses to CAR T-cell immunotherapy, according to a…
Takeda’s investigational therapy mezagitamab increased platelet counts in adults with persistent or chronic primary immune thrombocytopenia (ITP) in a Phase 2 trial,…
A woman with an extremely rare combination of three autoimmune diseases — immune thrombocytopenia (ITP), autoimmune hemolytic anemia (AIHA), and antiphospholipid syndrome — has been…
Oral dapsone, an antibiotic sometimes used in treatment-resistant cases, was linked to increased platelet counts in 58.6% of treated children, adolescents, and adults…
Pharma companies Galapagos and Gilead are in talks for a potential collaboration to develop gamgertamig, an experimental therapy for immune thrombocytopenia (ITP)…
Adjusting the dose of oral eltrombopag — the active ingredient in Alvaiz and Promacta — based on how much of the drug is present in…
Celebrities and advocacy groups are teaming up to raise awareness of bleeding disorders with a three-hour livestream celebrating the community. The March 28 event, “Bleeding.org…
U.S. researchers have created a prediction tool — one that uses laboratory tests collected at the time of diagnosis — to help identify which children…
